NYSE:LLY

Eli Lilly Stock News

Healthcare > Drug Manufacturers - General

Buy LLY

*Your capital is at risk

$1,231.58

+45.87 (+3.87%)

At Close: Aug 10, 2026

Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20

03:21pm, Friday, 20'th Jan 2023 Benzinga

Here's a round-up of stories from around the globe and from various media outlets. Benzinga Google To Fire 12K Employees Worldwide; Extends Support Packages Alphabet Inc.'s (NASDAQ: GOOG) (NASDAQ: G

Pharma Stock Roundup: LLY's Donanemab Gets FDA's CRL, MRNA RSV Jab Study Succeeds

02:23pm, Friday, 20'th Jan 2023 Zacks Investment Research

FDA gives CRL to Lilly's (LLY) Alzheimer's candidate, donanemab. Moderna's (MRNA) phase III study on its mRNA-based RSV vaccine candidate in older adults meets primary efficacy endpoints

FDA Rejects Accelerated Nod to Lilly's (LLY) Alzheimer's Drug

02:18pm, Friday, 20'th Jan 2023

The FDA rejects Eli Lilly's (LLY) seeking accelerated approval of a new Alzheimer's drug, donanemab, due to the limited number of patients with at least 12 months of drug exposure data.

Eli Lilly shares slide as US regulator wants more data on its potential Alzheimer's treatment

01:56pm, Friday, 20'th Jan 2023

Eli Lilly and Co (NYSE:LLY) shares sank after it emerged that the US Food and Drug Administration (FDA) said needed to see more data on the company's application to accelerate approval of its potenti

Tech Stocks Get Netflix Boost Amid Jittery Wider Market On Friday, Dow Stares At 4th Straight Loss

11:30am, Friday, 20'th Jan 2023 Benzinga

U.S. stocks look set for a positive start on Friday, reversing course from the sell-off seen in the past three sessions. What Happened: Traders may have to contend with Fed speeches and housing mark

In A Stunner, Eli Lilly Stock Falls After FDA Delivers A Blow To Its Alzheimer's Drug

09:58am, Friday, 20'th Jan 2023

Eli Lilly stock dipped Friday after the FDA unexpectedly rejected its request for an accelerated approval of its Alzheimer's treatment. The post In A Stunner, Eli Lilly Stock Falls After FDA Delivers

Why the FDA didn't grant an approval to Lilly's Alzheimer's drug

09:23am, Friday, 20'th Jan 2023

Eli Lilly & Co. LLY, -0.26% now plans to seek full approval of its experimental Alzheimer's disease treatment after the Food and Drug Administration refused to grant a speedier approval using less rig

FDA rejects Eli Lilly's proposed Alzheimer's treatment, says more data needed

12:16am, Friday, 20'th Jan 2023 MarketWatch

The setback could delay a potential commercial introduction of the highly anticipated drug by at least several months, if the Food and Drug Administration eventually decides to approve it.

FDA rejects Eli Lilly's proposed Alzheimer's treatment, says more data needed

07:16pm, Thursday, 19'th Jan 2023

U.S. drug regulators rejected Eli Lilly & Co.'s proposed new Alzheimer's disease treatment, saying they need more data from clinical testing, according to the company.

Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide

05:19pm, Thursday, 19'th Jan 2023 Benzinga

Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023. In large-cap land, there two two o

Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results Announcement

10:00am, Thursday, 19'th Jan 2023

INDIANAPOLIS , Jan. 19, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2022 financial results on Thursday, Feb. 2, 2023. Lilly will also conduct a conference c